Dataset Information


Advances on chimeric antigen receptor-modified T-cell therapy for oncotherapy.

ABSTRACT: Tumor treatment is still complicated in the field of medicine. Tumor immunotherapy has been the most interesting research field in cancer therapy. Application of chimeric antigen receptor T (CAR-T) cell therapy has recently achieved excellent clinical outcome in patients, especially those with CD19-positive hematologic malignancies. This phenomenon has induced intense interest to develop CAR-T cell therapy for cancer, especially for solid tumors. However, the performance of CAR-T cell treatment in solid tumor is not as satisfactory as that in hematologic disease. Clinical studies on some neoplasms, such as glioblastoma, ovarian cancer, and cholangiocarcinoma, have achieved desirable outcome. This review describes the history and evolution of CAR-T, generalizes the structure and preparation of CAR-T, and summarizes the latest advances on CAR-T cell therapy in different tumor types. The last section presents the current challenges and prospects of CAR-T application to provide guidance for subsequent research.


PROVIDER: S-EPMC5956614 | BioStudies | 2018-01-01

REPOSITORIES: biostudies

Similar Datasets

2020-01-01 | S-EPMC7556036 | BioStudies
2017-01-01 | S-EPMC5601024 | BioStudies
2016-01-01 | S-EPMC5214859 | BioStudies
2018-01-01 | S-EPMC6126939 | BioStudies
2019-01-01 | S-EPMC6543840 | BioStudies
2021-01-01 | S-EPMC7738987 | BioStudies
2016-01-01 | S-EPMC5358667 | BioStudies
2017-01-01 | S-EPMC5532628 | BioStudies
2018-01-01 | S-EPMC5943172 | BioStudies
2017-01-01 | S-EPMC5223234 | BioStudies